CDC

ACIP recommends updated COVID-19 booster for enhanced protection

December 16, 2024

ACIP now recommends that all persons ≥65 years, as well as those aged 6 months to 64 years with moderate or severe immunocompromise, receive a second 2024–2025 COVID-19 vaccine dose six months after their last dose. Additionally, individuals ≥6 months with moderate or severe immunocompromise may receive further doses based on shared clinical decision-making. Previously, ACIP recommended COVID-19 vaccination for all persons aged ≥6 months. This updated guidance aims to enhance protection for vulnerable populations against evolving COVID-19 variants.

Source:

Roper LE, et al. (2024, December 12). CDC. Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024. https://www.cdc.gov/mmwr/volumes/73/wr/mm7349a2.htm